Breeze Acquisition II Prices $125 Million Nasdaq IPO

SPAC Prices $125 Million Initial Public Offering

Breeze Acquisition Corp. II, a special purpose acquisition company, announced the pricing of its initial public offering of 12.5 million units at $10.00 each. The offering successfully raised gross proceeds of $125 million before underwriting discounts and commissions.

Offering Details and Market Debut

The units are scheduled to commence trading on the Nasdaq Global Market on May 13, 2026, under the ticker symbol "BREZU." Each unit is composed of one ordinary share and one right, which entitles the holder to receive one-fifth of an ordinary share upon the completion of an initial business combination. Following the initial listing, the ordinary shares and rights are expected to trade separately under the symbols "BREZ" and "BREZR," respectively. The offering is anticipated to close on or about May 14, 2026.

Strategic Focus and Use of Proceeds

As a blank check company, Breeze Acquisition Corp. II intends to use the net proceeds from the IPO to fund a business combination. The company's search will focus on target businesses with global operations and robust technology capabilities. Key sectors of interest include healthcare, biotechnology, advanced manufacturing, robotics, and artificial intelligence.

Summary

The successful pricing of this IPO provides Breeze Acquisition Corp. II with significant capital to pursue an acquisition in high-growth technology and healthcare-related industries. The market will now watch for the company's next steps in identifying and merging with a suitable target business.

FAQ

Q: What is Breeze Acquisition Corp. II?
A: It is a blank check company, also known as a SPAC, incorporated for the purpose of effecting a merger, share exchange, asset acquisition, or other similar business combination with one or more businesses.

Q: What is the structure of each unit sold in the IPO?
A: Each unit consists of one ordinary share and one right to receive one-fifth of one ordinary share upon a business combination.

Q: Which sectors is the company targeting for acquisition?
A: The company is focused on businesses in healthcare, biotechnology, advanced manufacturing, robotics, and artificial intelligence.

Source: Investing.com